StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AcquisitionsJul 1, 2026, 04:14 PM

Genenta Science Completes Sòphia High Tech Acquisition; Appoints New Directors

AI Summary

Genenta Science S.p.A. announced the completion of its acquisition of a majority equity ownership in Sòphia High Tech S.r.l., following the satisfaction of all closing conditions, including Italian 'Golden Power' authorization. The company also reported the appointment of new directors to its Board. Additionally, an Extraordinary Shareholders' Meeting, which included proposals for a corporate name change and share capital increase, was adjourned to July 29, 2026, to allow for further shareholder engagement.

Key Highlights

  • Genenta Science completed the acquisition of a majority equity ownership in Sòphia High Tech S.r.l.
  • The transaction closed after obtaining authorization under Italian 'Golden Power' legislation.
  • The Extraordinary Shareholders' Meeting was adjourned to July 29, 2026, for further shareholder engagement.
  • New directors appointed include Francesco Dagnino, Miguel Maria Mutti, Armon R. Sharei, and Riccardo Palmisano.
  • The term of office for new directors is three years, with aggregate annual compensation of €165,000.
  • Authorization for treasury share purchase and disposal for 18 months, up to 30% of share capital, was approved.